Author | Timothy P. Hughes, MD | OncLive

Author | Timothy P. Hughes, MD

Articles

Dr. Hughes on Switching From Imatinib to Nilotinib in CML

January 04, 2013

Video

Timothy P. Hughes, MD, MBBS, explains the two-year follow-up results of the ENESTcmr trial analyzing the switch to nilotinib after at least 2 years on imatinib in patients with chronic phase chronic myeloid leukemia.

x